CC BY-NC-ND 4.0 · Journal of Gastrointestinal Infections 2023; 13(01): 017-025
DOI: 10.1055/s-0043-1768701
Systematic Review

Systematic Review and Meta-Analysis: Risk of Post-ERCP Cholangitis with Air or CO2 versus Contrast Cholangiography in Perihilar Malignant Biliary Obstruction

1   Department of Gastroenterology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
,
Sidharth Harindranath
2   Department of Gastroenterology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India
,
3   Department of Gastroenterology, All India Institute of Medical Science Bhubaneswar, Bhubaneswar, Orissa, India
,
Lohith Kumar
1   Department of Gastroenterology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
,
4   Department of Digestive Diseases and Clinical Nutrition, Tata Memorial Hospital, Mumbai, Maharashtra, India
› Author Affiliations


Abstract

Background Endoscopic retrograde cholangiopancreatography (ERCP) may be associated with a risk of postprocedural cholangitis in case of failed drainage of the injected contrast. The present meta-analysis was conducted to assess whether air cholangiography reduces the risk of post-ERCP cholangitis compared with contrast injection.

Methods A comprehensive search of MEDLINE, EMBASE, and Science Direct from inception to September 2022 was done for studies comparing air or CO2 and contrast agent for cholangiography during ERCP, with the last search on September 31, 2022. Dichotomous outcomes were analyzed using risk ratios (RRs) with 95% confidence intervals (CIs).

Results A total of seven studies were included in the final analysis. Among these, there were three randomized trials and four retrospective studies. The included studies had moderate to high risk of bias. There was no difference in the clinical success rate (RR: 1.02, 95% CI: 0.94–1.09; I 2 = 0%), but a lower risk of all-cause adverse events (AEs) (RR: 0.21, 95% CI: 0.12–0.36; I 2 = 0%) with air cholangiography, compared with contrast cholangiography. Concerning individual AEs, this difference was seen only for cholangitis (RR: 0.51, 95% CI: 0.37–0.69; I 2 = 0%) but not for post-ERCP pancreatitis, perforation, and bleeding. Reintervention and 30-day mortality remained comparable between groups. The certainty of evidence remained low to very low.

Conclusion Air or CO2 cholangiography reduces the risk of overall AE, especially post-ERCP cholangitis, compared with contrast cholangiography. Further trials are required to validate the findings of the study.

Authors' Contribution

Conceptualization: S.G., S.S.; Data curation: S.G., S.H., P.A.; Formal analysis: S.G., S.H., P.A., L.K.; Funding acquisition: N/A; Investigation: S.G., S.H., L.K.; Methodology: S.G., S.H., P.A., S.S.; Project administration: S.G., S.S.; Resources: S.G., S.H., S.S.; Software: S.G.; Supervision: S.S.; Validation: S.G., S.H., S.S.; Visualization: S.G.; Roles/Writing - original draft: S.G., S.H., P.A.; Writing - review & editing: S.G., S.H., P.A., L.K., S.S.


Supplementary Material



Publication History

Received: 22 February 2023

Accepted: 05 April 2023

Article published online:
22 September 2023

© 2023. Gastroinstestinal Infection Society of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Zhang W, Yan LN. Perihilar cholangiocarcinoma: current therapy. World J Gastrointest Pathophysiol 2014; 5 (03) 344-354
  • 2 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr 2014; 3 (01) 18-34
  • 3 Ishigaki T, Sasaki T, Serikawa M. et al. Evaluation of antibiotic use to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis. Hepatogastroenterology 2015; 62 (138) 417-424
  • 4 Singh V, Singh G, Verma GR, Singh K, Gulati M. Contrast-free unilateral endoscopic palliation in malignant hilar biliary obstruction: new method. J Gastroenterol Hepatol 2004; 19 (05) 589-592
  • 5 Singh V, Singh G, Gupta V, Gupta R, Kapoor R. Contrast-free air cholangiography-assisted unilateral plastic stenting in malignant hilar biliary obstruction. Hepatobiliary Pancreat Dis Int 2010; 9 (01) 88-92
  • 6 Sud R, Puri R, Hussain S, Kumar M, Thawrani A. Air cholangiogram: a new technique for biliary imaging during ERCP. Gastrointest Endosc 2010; 72 (01) 204-208
  • 7 Pisello F, Geraci G, Modica G, Sciumè C. Cholangitis prevention in endoscopic Klatskin tumor palliation: air cholangiography technique. Langenbecks Arch Surg 2009; 394 (06) 1109-1114
  • 8 Lee JM, Lee SH, Jang DK. et al. Air cholangiography in endoscopic bilateral stent-in-stent placement of metallic stents for malignant hilar biliary obstruction. Therap Adv Gastroenterol 2016; 9 (02) 189-198
  • 9 Zhang WH, Ding PP, Liu L. et al. CO2 or air cholangiography reduces the risk of post-ERCP cholangitis in patients with Bismuth type IV hilar biliary obstruction. BMC Gastroenterol 2020; 20 (01) 189
  • 10 Trabanco S, Pardo S, Williams M, Diaz J, Ruiz C. Cerebral air embolism after ERCP. J Clin Anesth 2017; 36: 133-135
  • 11 Bisceglia M, Simeone A, Forlano R, Andriulli A, Pilotto A. Fatal systemic venous air embolism during endoscopic retrograde cholangiopancreatography. Adv Anat Pathol 2009; 16 (04) 255-262
  • 12 Sterne JA, Hernán MA, Reeves BC. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919
  • 13 Higgins JP, Altman DG, Gøtzsche PC. et al; Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928
  • 14 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372 (71) n71
  • 15 Zhang R, Zhao L, Liu Z. et al. Effect of CO2 cholangiography on post-ERCP cholangitis in patients with unresectable malignant hilar obstruction - a prospective, randomized controlled study. Scand J Gastroenterol 2013; 48 (06) 758-763
  • 16 Sud R, Puri R, Choudhary NS, Mehta A, Jain PK. Air cholangiogram is not inferior to dye cholangiogram for malignant hilar biliary obstruction: a randomized study of efficacy and safety. Indian J Gastroenterol 2014; 33 (06) 537-542
  • 17 Elshimi E, Attia AE, Eljaky A. et al. Successful biliary navigation using air in malignant and post-surgical hilar strictures: a prospective controlled trial. Res Rep Gastroenterol. 2018; 2: 1
  • 18 Zhang WH, Ding PP, Liu L. et al. CO2 or air cholangiography reduces the risk of post-ERCP cholangitis in patients with Bismuth type IV hilar biliary obstruction. BMC Gastroenterol 2020; 20 (01) 189
  • 19 He QB, Zheng RH, Wang Y. et al. Using air cholangiography to reduce postendoscopic retrograde cholangiopancreatography cholangitis in patients with malignant hilar obstruction. Quant Imaging Med Surg 2022; 12 (03) 1698-1705
  • 20 Tang Z, Yang Y, Meng W, Li X. Best option for preoperative biliary drainage in Klatskin tumor: A systematic review and meta-analysis. Medicine (Baltimore) 2017; 96 (43) e8372
  • 21 Kondo H, Naitoh I, Nakazawa T. et al. Development of fatal systemic gas embolism during direct peroral cholangioscopy under carbon dioxide insufflation. Endoscopy 2016; 48 (Suppl. 01) E215-E216